DCR Ligand-Bearing Liposome-Encapsulated Melanoma Antigens Vaccine

A cancer cell-based vaccine containing liposome encapsulated melanoma antigens and an immunomodulatory factor, attached, via a metal chelator, to a dendritic cell receptor (DCR) ligand-containing a metal-affinity tag, with potential immunomodulating and antineoplastic activity. Upon intravenous administration of DCR ligand-bearing liposome-encapsulated melanoma antigens vaccine, the DCR ligand moiety of this vaccine targets receptors on dendritic cells (DCs), thereby presenting the antigens to DCs which may, in turn, stimulate the DCs and may activate the immune system to mount a cytotoxic T lymphocyte (CTL) response against melanoma cancer cell associated antigens. (NCI Thesaurus)

YOU MAY ALSO LIKE

DCN wt Allele

Human DCN wild-type allele is located in the vicinity of 12q21.33 and is approximately 38 kb in length. This allele, which encodes…

DCN Gene

This gene plays a role in proteoglycan synthesis.

DCLRE1C wt Allele

Human DCLRE1C wild-type allele is located in the vicinity of 10p13 and is approximately 97 kb in length. This allele, which encodes…

DCLRE1C Gene

This gene is involved in both DNA repair and V(D)J recombination.

DCLRE1B wt Allele

Human DCLRE1B wild-type allele is located in the vicinity of 1p13.2 and is approximately 9 kb in length. This allele, which encodes…

DCLRE1B Gene

This gene is involved in DNA repair.